New Brain Cell Discovery Could Unlock Secrets to Alzheimer's-Related Disorientation

Researchers have identified a unique neuron in the retrosplenial cortex that encodes the sense of direction, offering new insights into Alzheimer’s-related disorientation and potential avenues for treatment.
Losing your sense of direction is among the earliest and most troubling signs encountered in advanced Alzheimer’s disease. Recent research from the University of Michigan has identified a distinctive neuron in the brain's retrosplenial cortex that may be pivotal in understanding this disorientation. This brain region, long associated with spatial orientation, exhibits a unique neuron type capable of consistently encoding an individual’s sense of direction, regardless of whether they are stationary or moving. According to Omar Ahmed, associate professor of psychology and senior author of the study, these specialized cells have evolved specifically to address a fundamental survival challenge: maintaining awareness of one's orientation at all times, be it during daily activities or emergency situations.
The study highlights that these neurons differ significantly from neighboring cells, expressing distinct genes and processing information in unique ways. Notably, they do not respond to acetylcholine in the same manner as other neurons—a chemical that typically increases during attention or physical activity—yet they continue to reliably track head rotation and orientation. This capability might explain why Alzheimer's patients often become disoriented even in familiar environments.
Inhibiting navigation and spatial memory, early impairments in the retrosplenial cortex are linked to the disorientation observed in Alzheimer’s disease. The research team is investigating how these neurons function in mouse models of Alzheimer’s, as well as examining their status in affected human brains, aiming to develop strategies to preserve or restore this critical function. Ultimately, understanding these unique cells could lead to breakthroughs in preventing or managing disorientation in neurodegenerative conditions.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Breakthrough in Cancer Diagnosis: Novel Fusion Gene Identified in Adenoid Cystic Carcinoma
Researchers identify a new fusion gene, NFIB::PHACTR2, crucial for accurately diagnosing adenoid cystic carcinoma, highlighting the importance of molecular testing in cancer diagnosis.
Advancements in Designing Superior Bispecific T-Cell Engagers for Cancer Treatment
New research uncovers key structural parameters that enhance the potency of bispecific T-cell engagers, promising improved cancer immunotherapy treatments.
Virtual Trial Indicates Combination Rescue Inhaler Significantly Reduces Severe Asthma Attacks
A groundbreaking virtual trial demonstrates that adding an inhaled corticosteroid to rescue therapy nearly halves severe asthma attacks, offering new hope for mild asthma management.



